The broad utility of halogens in medicinal chemistry has motivated application of hybrid quantum-and molecular-mechanical methods. Extending these concepts to a therapeutic protein (insulin), iodination of a conserved tyrosine at position B26 was recently shown to enhance key properties of a rapidacting clinical analog, including its thermodynamic stability and resistance to fibrillation. Here, we (i) describe quantitative atomic-level simulations of the mono-iodininated insulin to predict its structural features and (ii) test these predictions by X-ray crystallography and multidimensional NMR spectroscopy. Using an electrostatic model of the modified aromatic ring based on quantum chemistry, the calculations suggested that the analog-as a dimer and hexamer-exhibits subtle differences in aromatic-aromatic interactions at the dimer interface. Eight aromatic rings at this interface (residues B16, B24-B26 and their dimer-related mates) must reorganize to enable packing of the hydrophobic iodine atoms within the core of each monomer. Strikingly, these features were observed in the crystal structure of the mono-iodonated insulin analog (determined as a zinc hexamer at 2.3 Å resolution). Given that residues B24-B30 detach from the core on receptor binding, the environment of the 3-iodo-tyrosine at position B26 in a hormone-receptor complex must differ from that in the free hormone. Based on the recent structure of a ''micro-receptor'' complex, we predict that more marked reorientation of the modified tyrosine at the receptor interface enables directional halogen bonding and halogen-directed hydrogen bonding: favorable electrostatic interactions exploiting, respectively, the halogen's electron-deficient s-hole and electronegative equatorial band. Thus, inspired by quantum chemistry and molecular dynamics, such ''halogen engineering'' promises to extend principles of medicinal chemistry to proteins. Extensions of this approach to fluoro-aromatic, chloro-aromatic systems, and bromo-aromatic systems in non-standard protein design and their potential therapeutic applications will also be discussed. Department of Chemical Sciences, University of Naples Federico II, Napoli, Italy. Sweet proteins are a family of proteins with no structural homology, able to elicit a sweet sensation by interacting with the dimeric T1R2-T1R3 sweet receptor [Picone, D. and Temussi, P.A., 2012, Plant science, 195, 135-142]. Our studies focus on MNEI, a single chain derivative of the natural protein monellin, representing one of the sweetest molecules known to date. MNEI stimulates a strong interest for its biological properties, but is also a well accepted model for protein folding and aggregation studies. In the framework of the ''wedge model'' [Temussi, P.A., 2009, TIBS, 34, 296-302], we have integrated computational and experimental techniques to enhance sweetness and stability of MNEI against physical and chemical agents [Leone S., et al., 2016, Scientific Reports, 6, 34045]. Based on molecular modeling, NMR [Spadaccini, R., et al., 2016, FEBS Lett, (in press)], and X-ray crystallography, we designed the sweetest protein ever obtained, which combines a sweetness threshold of about 25 nM with a very high and pH-independent thermal stability. Docking studies have provided a rationale basis to explain these properties, hinting at a previously unpredicted role of plasticity in the interaction between this protein and the sweet receptor. Additional aspects of protein aggregation and unfolding properties studied by Molecular Dynamics [Leone S. and Picone, D., 2016, PloS one, 11 (6), e0158372], Atomic Force Microscopy and Optic Spectroscopies will be also discussed. Biochemistry and Molecular Biology, University of Chicago, Chicago, IL, USA. Understanding the physical and chemical principles governing specificity in protein-protein binding is important both for revealing mechanisms of molecular recognition and for designing novel biomolecular systems. The protein families Dprs and DIPs, comprised of 21 and 9 immunoglobulin superfamily (IgSF) proteins, respectively, mediate neural cell adhesions and are critical for synapse formation specificity during development in arthropods. Previous research has recently characterized the Dpr-DIP interaction network and found that each Dpr selectively interacts with specific DIPs; the synaptic connectivity pattern in the fly brain is encoded by this molecular interaction network. The goal of this project is to determine the molecular basis of the specificity of these interactions. To achieve this goal, we are computing the binding free energies of each possible Dpr-DIP interaction using both the Molecular MechanicsPoisson Boltzmann Surface Area (MM-PBSA) approach and potential of mean force (PMF) based framework, constructed from all atom molecular dynamics (MD) simulations. We are also employing a new near-atomic level MD program, Upside, to rapidly sample possible poses. Due to the lack of highresolution crystal structures for most of these interactions, homology modeling was used in order to generate the initial structures. The calculated binding free energies will be used to predict possible Dpr-DIP interactions. Ultimately, we hope to use our current approach to predict potential protein-protein interactions between other IgSF proteins, which make up the second largest protein family in the human proteome, and are crucial for the development and function of the nervous and immune systems.
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